China Meheco Group Co., Ltd.

600056

CNE000000Q29

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
10.98 ^CNY	+0.73%		-1.79%	-1.70%

Apr. 26	China Meheco Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 20	Meheco's Unit Gets Nod to Raise Specifications for Piperacillin Sodium for Injection	MT

China Meheco Group Co., Ltd. agreed to acquire 46% stake in Hainan General Kangli Pharmaceutical Co., Ltd. from General Technology Group Pharmaceutical Holding, Ltd. for CNY 190 million.

December 22, 2023

China Meheco Group Co., Ltd. (SHSE:600056) agreed to acquire 46% stake in Hainan General Kangli Pharmaceutical Co., Ltd. from General Technology Group Pharmaceutical Holding, Ltd. for CNY 190 million on December 19, 2023.

Latest news about China Meheco Group Co., Ltd.

China Meheco Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 26	CI
Meheco's Unit Gets Nod to Raise Specifications for Piperacillin Sodium for Injection	Feb. 20	MT
Argatroban Injection of Meheco's Subsidiary Passes Chinese Drug Regulator's Evaluation	Feb. 20	MT
Meheco's Unit Gets Nod to Market Peramivir Injection; Shares Down 4%	Feb. 05	MT
Meheco Unit's Antibiotic Passes Regulatory Evaluation in China	Jan. 24	MT
China Meheco Group Co., Ltd. agreed to acquire 46% stake in Hainan General Kangli Pharmaceutical Co., Ltd. from General Technology Group Pharmaceutical Holding, Ltd. for CNY 190 million.	Dec. 22	CI
Genertec Universal, Parent Form 2 Billion Yuan Fund	Dec. 22	MT
China Meheco’s Hypertension Drug Passes Generic Consistency Evaluation	Nov. 16	MT
China Meheco Group's Drugs Chosen for China's Centralized Drug Procurement	Nov. 08	MT
China Meheco Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
China Meheco Group Unit's Norfloxacin Capsules Passes Drug Regulator's Evaluation	23-10-13	MT
China Meheco’s Antibiotic Passes Generic Consistency Evaluation	23-10-04	MT
China Meheco Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
China Medicine Health Industry Gets Registration Certificate for Sitafloxacin Tablets	23-06-16	MT
China Meheco Group Co., Ltd.(SHSE:600056) added to Shanghai Stock Exchange 180 Value Index	23-06-12	CI
China Meheco Group Co., Ltd.(SHSE:600056) added to SSE 180 Index	23-06-12	CI
New rules to dampen Chinese interest to list in Europe, say bankers	23-05-22	RE
China Meheco Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
China Meheco Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
China Medicine Health Industry Unit Gets Regulatory Nod for Gastrointestinal Bleeding Drug	23-03-08	MT
China Medicine Health Industry Unit's Injection Passes Regulator's Consistency Evaluation	23-03-06	MT
China Meheco’s Generic Azithromycin Passes Consistency Test	23-02-27	MT
China Meheco Rents Office Property for 57 Million Yuan	23-02-13	MT
Meheco Unit's Anti-Bacterial Injection Passes Regulator's Evaluation	23-02-03	MT
Paxlovid sales forecasts may change with Pfizer view on China	23-01-30	RE

Chart China Meheco Group Co., Ltd.

Duration

Period

More charts

Company Profile

China Meheco Group Co., Ltd. is mainly engaged in the operation of industrial pharmaceutical, commercial pharmaceutical and international trading businesses. Industrial Pharmaceutical segment mainly involves in the manufacture and distribution of chemical preparations, chemical bulk drugs, biological products, Chinese patent medicine, herbal decoction pieces and other pharmaceutical products. Commercial Pharmaceutical segment is mainly engaged in the wholesale and distribution of pharmaceuticals and medical devices. Trading segment is mainly engaged in the international exporting business and medical resourcing introduction.

Sector

Pharmaceuticals

Calendar

2024-04-29 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
CHINA MEHECO GROUP CO., LTD.	-1.70%	2.27B
MCKESSON CORPORATION	+17.35%	71.39B
CARDINAL HEALTH, INC.	+2.39%	25.1B
SINOPHARM GROUP CO. LTD.	+0.24%	8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+6.69%	8.19B
HUADONG MEDICINE CO., LTD	-20.96%	7.91B
H. LUNDBECK A/S	+0.49%	4.54B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+17.12%	4.31B
GALENICA AG	-2.61%	3.86B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+22.08%	3.64B